{"id":"W4307160114","doi":"10.1053/j.seminoncol.2022.10.001","title":"IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time","year":2022,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Ipilimumab; Cabozantinib; Pembrolizumab; Axitinib; Sunitinib; Renal cell carcinoma; Oncology; Kidney cancer; Hazard ratio; Clinical trial; Progression-free survival; Cancer; Immunotherapy; Overall survival; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007954274,0.001492189,0.01174667,0.004885994,0.0003949708,0.002707605,0.001178155,0.001718308,0.004427825],"category_scores_gemma":[0.02770837,0.00115443,0.01660947,0.006122322,0.0009253796,0.0021974,0.001989769,0.001942042,0.0003103104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004387816,"about_ca_system_score_gemma":0.007292853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01038514,"about_ca_topic_score_gemma":0.03913163,"domain_scores_codex":[0.9938212,0.002112739,0.002391766,0.0006645683,0.0006906734,0.0003191356],"domain_scores_gemma":[0.9851981,0.008508842,0.004884627,0.0002523312,0.0009105367,0.0002455447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00182767,0.00002267243,0.002032527,0.8841968,0.09319116,0.00005665343,0.0002010372,0.0001590916,0.0002783404,0.0001267161,0.001039261,0.01686808],"study_design_scores_gemma":[0.003251229,0.0006555851,0.008688398,0.3535115,0.6224212,0.0002114729,0.00028488,0.0001352694,0.0002213213,0.0002930576,0.0102572,0.00006880741],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002497928,0.995684,0.0001494517,0.000206117,0.0001407165,0.000326277,0.0008081477,0.00001333979,0.0001739903],"genre_scores_gemma":[0.08208234,0.9135358,0.001057526,0.001459605,0.0001279059,0.0008356274,0.0005943484,0.00002052259,0.0002863679],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01174667,"threshold_uncertainty_score":0.04206669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03645426860760719,"score_gpt":0.3739355171632866,"score_spread":0.3374812485556794,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}